Gerrit Dispersyn is President at Phio Pharmaceuticals Corp. (PHIO). They have made 5 open-market trades across 2 companies since 2017, most recently 2022-03-01.
CIK 0001704417
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $30K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHIO | BUY | 2021-08-16 | 2021-08-17 | $1.63 | $10K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2021-03-04 | 2021-03-05 | $2.56 | $5K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2021-03-03 | 2021-03-03 | $3.03 | $8K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2020-08-19 | 2020-08-19 | $2.50 | $5K | -11.2% | +1.2% | +1.2% |
| RXII | BUY | 2017-06-23 | 2017-06-26 | $0.62 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.